Dermatitis Atopic Clinical Trials

Active, not recruiting

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

NCT06241118

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: University of Alabama at Birmingham- Site Number : 8401267 Birmingham, Alabama, United States

Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States

Arkansas Dermatology - North Little Rock- Site Number : 8401244 North Little Rock, Arkansas, United States

Encino Research Center- Site Number : 8401042 Encino, California, United States

View all 150 locations

View Trial Details

Active, not recruiting

Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials

NCT05492578

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Allervie Clinical Research - Birmingham- Site Number : 8401101 Birmingham, Alabama, United States

Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham, Alabama, United States

Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States

Scottsdale Clinical Trials- Site Number : 8401149 Scottsdale, Arizona, United States

View all 390 locations

View Trial Details

Active, not recruiting

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)

NCT03992417

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Investigational Site Number : 0320013 Pilar, Buenos Aires, Argentina

Investigational Site Number : 0320012 Rosario, Santa Fe Province, Argentina

Investigational Site Number : 0320011 Ciudad Autonoma Bs As, Argentina

Investigational Site Number : 0360002 Kogarah, New South Wales, Australia

View all 105 locations

View Trial Details

Active, not recruiting

A Study to Evaluate the Treatment Response and Safety of Two Dose Regimens of Subcutaneous Amlitelimab Compared With Treatment Withdrawal in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis

NCT06407934

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham, Alabama, United States

Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States

Scottsdale Clinical Trials- Site Number : 8401149 Scottsdale, Arizona, United States

Eclipse Clinical Research- Site Number : 8401158 Tucson, Arizona, United States

View all 324 locations

View Trial Details

Active, not recruiting

Open Label, Long-term Study Evaluating Safety and Efficacy of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate to Severe Atopic Dermatitis

NCT05769777

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Allervie Clinical Research - Birmingham- Site Number : 8400050 Birmingham, Alabama, United States

Research Solutions of Arizona- Site Number : 8400020 Litchfield Park, Arizona, United States

Dermatology Trial Associates- Site Number : 8400027 Bryant, Arkansas, United States

University Dermatology Trials- Site Number : 8400052 Newport Beach, California, United States

View all 174 locations

View Trial Details

Active, not recruiting

A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis

NCT05983068

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: National Jewish Health Medical Center- Site Number : 8400001 Denver, Colorado, United States

SSM Health Saint Louis University Hospital- Site Number : 8400006 St Louis, Missouri, United States

NYU Langone Medical Center- Site Number : 8400004 New York, United States

Investigational Site Number : 8260001 Sheffield, United Kingdom

View Trial Details

Active, not recruiting

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

NCT03687359

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: C Squared Research Center- Site Number : 8400068 Birmingham, Alabama, United States

Cahaba Dermatology & Skin Health Center- Site Number : 8400046 Birmingham, Alabama, United States

C2 Research Center, LLC- Site Number : 8400071 Montgomery, Alabama, United States

Phoenix Children's Hospital, Inc.- Site Number : 8400015 Phoenix, Arizona, United States

View all 182 locations

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab Monotherapy Compared With Placebo in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis (COAST 2)

NCT06181435

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States

Eclipse Clinical Research- Site Number : 8401158 Tucson, Arizona, United States

Torrance Clinical Research- Site Number : 8401027 Lomita, California, United States

Dermatology Research Associates - Los Angeles- Site Number : 8401092 Los Angeles, California, United States

View all 142 locations

View Trial Details

Completed

A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab in Participants Aged 12 Years and Older With Moderate-to-severe Atopic Dermatitis on Background Topical Corticosteroids

NCT06224348

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Cahaba Dermatology & Skin Health Center- Site Number : 8401066 Birmingham, Alabama, United States

Johnson Dermatology- Site Number : 8401076 Fort Smith, Arkansas, United States

Encino Research Center- Site Number : 8401042 Encino, California, United States

Marvel Clinical Research- Site Number : 8401102 Huntington Beach, California, United States

View all 167 locations

View Trial Details

Completed

A Study to Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

NCT06015308

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, Dermatitis Atopic, +9 more
Locations: Clinical Research Center of Alabama - Homewood- Site Number : 8401101 Birmingham, Alabama, United States

Center for Dermatology and Plastic Surgery- Site Number : 8401119 Scottsdale, Arizona, United States

Orange County Clinical Trials- Site Number : 8401271 Anaheim, California, United States

First OC Dermatology- Site Number : 8401025 Fountain Valley, California, United States

View all 57 locations

View Trial Details

Dermatitis Atopic

Dermatitis Atopic trial results

Related conditions